A single institutional subset analysis of the WJLCG study comparing concurrent and sequential chemoradiotherapy for stage III non-small-cell lung cancer

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 22, Issue 3, 2004, Pages 163-167

  Tada, Takuhito ^a   Minakuchi, Kazuo ^a   Matsui, Kaoru ^b   Kin, Hideki ^a   Nishiguchi, Tomokazu ^a   Fukuda, Haruyuki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

Chemotherapy; Interruption; Lung cancer; Radiotherapy

Indexed keywords

CISPLATIN; MITOMYCIN; VINDESINE;

ADULT; AGED; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; INFECTION; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; PROGNOSIS; RADIATION DOSE; RADIATION PNEUMONIA; REVIEW; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 3242763147     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ, 311: 899-909, 1995.
2. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med, 125: 723-729, 1996.
3. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med, 326: 524-530, 1992.
4. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol, 17: 2692-2699, 1999.
5. Cox JD, Pajak TF, Asbell S, et al. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys, 27: 493-498, 1993.
6. Tada T, Minakuchi K, Koda M, et al. Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy. Radiology, 208: 511-515, 1998.
7. Albain KS, Crowley JJ, Turrisi AT 3rd, et al. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol, 20: 3454-3460, 2002.